We let our customers speak on our behalf

One of our first customers was AstraZeneca. AstraZeneca is one of the world’s largest pharmaceutical companies with approximately 67,000 employees. AstraZeneca manufactures medical treatments for cancer, heart diseases, ulcers, infections, neurological diseases and asthma.

Besides AstraZeneca, iRecruit has been working together with some of the largest pharmaceutical companies in the world, helping them to increase their patient recruitments. Our customers operate in many different countries, different TA’s, spanning a variety of studies ranging from phase 0 to phase 4.

We know that the best marketing is the reference from previous customers. That is why we have gathered a small section of our customers to speak on our behalf. Enjoy!

As one of the biggest pharmaceutical companies, with operations across many different countries, it has been vital for us to work together with a company, which has a fast recruitment, without compromising on quality. We have been able to measure and track the entire recruitment funnel all the way from the pre-recruitment to the final delivery to sites.

iRecruit is the first company, which is offering a fully transparent recruitment plan, in which AstraZeneca only pays for eligible patients.

This ‘no cure – no pay’ solution is our guarantee for keeping the budget and reaching the target on time.

Since implementing iRecruit, we have seen a dramatic increase in eligible patients. The pre-qualified patients lower the pressure of the sites and reduce the total cost related to recruitment, compared to other recruitment methods.

iRecruit provides patient recruitment with a high ROI and high quality.

Heidi Egsgaard Frandsen

Heidi Egsgaard Frandsen
Lead clinical research associate, AstraZeneca